Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?Mirjana Urosevic, Patrick A Oberholzer, Tanja Maier, et al.Human Gene Therapy|February 11, 2005
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacyLucie Heinzerling, Günter Burg, Reinhard Dummer, et al.European Journal of Dermatology : EJD|August 12, 2008
Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndromeJoanna Mangana, Marie C Zipser, Curdin Conrad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitorsPatrick A Oberholzer, Damien Kee, Piotr Dziunycz, et al.Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
MEK1 mutations confer resistance to MEK and B-RAF inhibitionCaroline M Emery, Krishna G Vijayendran, Marie C Zipser, et al.The Journal of Investigative Dermatology|September 2, 2011
Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patientsWilliam M Lin, Julia M Lewis, Renata B Filler, et al.Blood|January 7, 2011
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeMichael K Kiessling, Patrick A Oberholzer, Chandrani Mondal, et al.Pageof 2